← Eichor
Condition: Subjective Drug Effects Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Subjective Drug Effects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Behavioral Pharmacology of Orally Administered THC and D-limonene
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06378957Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
NA · 1 location(s) · Roswell Park Cancer Institute · NCT07102082Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Percept
Phase 1 · 2 location(s) · Food and Drug Administration (FDA) · NCT07176208Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjecti
NA · 1 location(s) · Roswell Park Cancer Institute · NCT07107139
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.